Back
Viatris 10K Form
Sell
36
VTRS
Viatris
Last Price:
13.1400
Seasonality Move:
5.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-05-10 | 10Q | VTRS/Viatris Quarterly |
| 2021-03-01 | 10K | VTRS/Viatris Annual |
| 2020-11-10 | 10Q | VTRS/Viatris Quarterly |
| 2020-08-12 | 10Q | VTRS/Viatris Quarterly |
| 2020-05-12 | 10Q | VTRS/Viatris Quarterly |
| 2020-05-07 | 10K | VTRS/Viatris Annual |
Receive VTRS News And Ratings
See the #1 stock for the next 7 days that we like better than VTRS
VTRS Financial Statistics
Sales & Book Value
| Annual Sales: | $15.43B |
|---|---|
| Cash Flow: | $741.1M |
| Price / Cash Flow: | 8.26 |
| Annual Sales: | $16.58 |
| Price / Book: | 0.78 |
Profitability
| EPS (TTM): | -0.74000 |
|---|---|
| Net Income (TTM): | $-883.3M |
| Gross Margin: | $6.44B |
| Return on Equity: | -4.39% |
| Return on Assets: | -1.89% |
Viatris Earnings Forecast
Key Viatris Financial Ratios
- The Gross Profit Margin over the past 40 years for VTRS is 41.74%.
- The Selling, General & Administrative Expenses for VTRS have been equal to 30.14% of Gross Profit Margin.
- The Research & Development expenses have been 5.22% of Revenue.
- The Interest Expense is 1,047.71% of Operating Income.
- The Net Earning history of VTRS is 0.35% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 27 years.
Viatris Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | VTRS |
| CUSIP: | 92556V |
| Website: | viatris.com |
Debt
| Debt-to-Equity Ratio: | 0.8 |
|---|---|
| Current Ratio: | 1.51 |
| Quick Ratio: | 0.8 |
Price-to-Earnings
| Trailing P/E Ratio: | 260 |
|---|---|
| Forward P/E Ratio: | 4.9 |